Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

NCT03173534 is registered in ClinicalTrials.gov with samir kapadia as lead sponsor.

NCT NCT03173534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03173534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
Lead sponsor
samir kapadia
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2017
Completion date
December 6, 2022
Enrollment
350 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, atrial fibrillation